Top Markets
#1 The Bitcoin Bull The Bitcoin Bull +29.50%
#2 Mubarak Mubarak +29.14%
#3 Dash Dash +22.15%
#4 Official Trump Official Trump +21.81%
#5 EXOD EXOD +18.93%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +17.43%
#7 Binance-Peg ZEC Binance-Peg ZEC +16.52%
#8 NEAR Intents Bridged ZEC NEAR Intents Bridged ZEC +16.37%
#9 Unit Zcash Unit Zcash +16.37%
#10 Zcash Zcash +16.37%
Coin of the day
The Bitcoin Bull The Bitcoin Bull
Settings
Language
ENGLISH
Currency
USD
Theme
ImageneBio Inc ImageneBio Inc

ImageneBio Inc

IMA
Rank in Stocks #24235
ImageneBio Inc (IMA) is a biotechnology company with therapies currently... ImageneBio Inc (IMA) is a biotechnology company with therapies currently undergoing human trials. The firm concentrates on creating innovative medical treatments for a variety of immune-related and inflammatory diseases. A key component of their pipeline is IMG-007, a non-depleting anti-OX40 monoclonal antibody, which is now in Phase 2b clinical studies targeting atopic dermatitis.
Share Price
$5.61
Last synced: 2026-08-21
Market Cap
$63.22M
Change (1 day)
-0.09%
Change (1 year)
-60.61%
Country
US
Trade ImageneBio Inc (IMA)

Category

Healthcare
Revenue for ImageneBio Inc (IMA)
Revenue in Aug 2026 TTM: 0
According to ImageneBio Inc latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for ImageneBio Inc from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH